Resnick, Chodorow & Associates wrote a white paper on quality of care for patients with type 2 diabetes and heart failure for the National Committee for Quality Assurance. Click here to read the report.
Resnick, Chodorow & Associates researched and wrote issue briefs for the Patient Access Network Foundation on the topic of cost-sharing for prescription medications. Click here to read the briefs.
Resnick, Chodorow & Associates worked with the American Society for Parenteral and Enteral Nutrition to write and publish the society's research agenda. Click here to read the research agenda.
Resnick, Chodorow & Associates was responsible for the systematic literature review and meta analysis for a Cystic Fibrosis Foundation clinical practice guideline on CFTR modulators. Click here to read the guideline.
Resnick, Chodorow & Associates provided methodologic expertise on a systematic review of the literature on microscopic hematuria screening for the American Urogynecologic Society. Click here to read the review.
Resnick, Chodorow & Associates provided expertise on study design and data collection to NORC at the University of Chicago for a project that evaluated study design options for the Long-Term Care Ombudsman Program. Click here to read the evaluation design.
Resnick, Chodorow & Associates supported the American Academy of Otolaryngic Allergy to produce an evidence review of clinical trial data that led to regulatory approval of biologic agents for treatment of conditions that are relevant to otolaryngology and allergy. Click here to read the review.
Resnick, Chodorow & Associates wrote a meeting summary on public trust in science for the National Academies of Science, Engineering, and Medicine. Click here to read the proceedings report.
Copyright © 2018 Resnick, Chodorow & Associates - All Rights Reserved.